Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Semaglutide for the Treatment of Opioid Use Disorder: A Pilot Randomized Controlled Trial

NCT06639464 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT06639464
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06639464 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Semaglutide for the Treatment of Opioid Use Disorder: A Pilot Randomized Controlled Trial
Lead sponsor
Brigham and Women's Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
June 2, 2025
Completion date
September 15, 2027
Enrollment
46 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use disorder